Family · Pharmaceutical analytical standards
Vonoprazan
A potassium-competitive acid blocker (P-CAB), first marketed in Japan in 2015 and used for reflux, ulcers and Helicobacter pylori eradication. This family brings together the active ingredient, labelled standards, nitrosamines and other impurities.
Did you know?Unlike proton pump inhibitors it does not need an acidic environment to become active, which is why it reaches full effect from the first day.
No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
